- Home
- PULM vs BMRA Comparison
PULM vs BMRA Comparison
Compare PULM & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- BMRA
- Stock Information
- Founded
- PULM 2003
- BMRA 1971
- Country
- PULM United States
- BMRA United States
- Employees
- PULM N/A
- BMRA N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PULM Health Care
- BMRA Health Care
- Exchange
- PULM Nasdaq
- BMRA Nasdaq
- Market Cap
- PULM 7.4M
- BMRA 7.4M
- IPO Year
- PULM N/A
- BMRA N/A
- Fundamental
- Price
- PULM $6.12
- BMRA $0.31
- Analyst Decision
- PULM
- BMRA
- Analyst Count
- PULM 0
- BMRA 0
- Target Price
- PULM N/A
- BMRA N/A
- AVG Volume (30 Days)
- PULM 1.3M
- BMRA 353.4K
- Earning Date
- PULM 11-08-2024
- BMRA 01-14-2025
- Dividend Yield
- PULM N/A
- BMRA N/A
- EPS Growth
- PULM N/A
- BMRA N/A
- EPS
- PULM N/A
- BMRA N/A
- Revenue
- PULM $10,005,000.00
- BMRA $5,509,000.00
- Revenue This Year
- PULM N/A
- BMRA N/A
- Revenue Next Year
- PULM $1.00
- BMRA N/A
- P/E Ratio
- PULM N/A
- BMRA N/A
- Revenue Growth
- PULM 47.05
- BMRA 1.74
- 52 Week Low
- PULM $1.55
- BMRA $0.24
- 52 Week High
- PULM $8.44
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- PULM 75.98
- BMRA 39.52
- Support Level
- PULM $5.28
- BMRA $0.30
- Resistance Level
- PULM $8.44
- BMRA $0.34
- Average True Range (ATR)
- PULM 1.01
- BMRA 0.03
- MACD
- PULM 0.35
- BMRA -0.01
- Stochastic Oscillator
- PULM 63.98
- BMRA 14.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.